DSM-5 on the right track with autism
A new study indicates that the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), was on the right track when it changed its autism symptom structure.
A new study indicates that the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), was on the right track when it changed its autism symptom structure. The study, which is the first to compare the DSM-5 structure to other models in toddlers, concludes that the new structure supports a diagnosis of autism spectrum disorder (ASD) in children aged as young as 1 year.
The study, led by researchers from Florida State University, looked at 237 toddlers aged between 12 and 30 months and diagnosed with ASD. The investigators assessed the children using 4 models: 1) the new DSM-5 model, which added the 2 new symptom domains of social communication/social interaction and restricted, repetitive interests and behaviors; 2) the DSM-IV model, which is comprised of 3 domains (ie, communication, social interaction, and restricted, repetitive interests and behaviors); 3) another validated model by van Lang and colleagues with 3 domains (ie, social communication, stereotyped speech and behaviors, and play skills); and 4) a model comprised of 1 symptom domain.
The study found that the DSM-5 symptom structure was the most useful and applicable, while the model with 1 symptom domain was the least appropriate. Specifically, the changes to the DSM-5 model that made it a better fit were that it added 1 new symptom (hypo- or hyperreactivity to sensory input/unusual sensory interests), removed 2 symptoms (delay in expressive language and impaired functional play skills), and reorganized some symptoms. For example, it categorized stereotyped and repetitive language with stereotyped and repetitive behaviors. Also, it combined several communication and social Interaction symptoms.
The study concluded that the new 2-domain model is appropriate for children aged as young as 12 to 30 months, which is important because it is the age at which symptoms begin to emerge.
The Centers for Disease Control and Prevention recommends screening all children for developmental delays and disabilities during well-child visits at 9, 18, and 24 or 30 months, with possible additional screening for children born prematurely or of low birth weight. In addition, all children should be screened specifically for ASDs during well-child visits at 18 and 24 months.
To get weekly clinical advice for today's pediatrician, subscribe to the Contemporary Pediatrics eConsult.
Paternal depression associated with adverse childhood experiences in children
October 21st 2023In this Q&A, Kristine H. Schmitz, MD, explains her team's recent research on paternal depression and adverse childhood experiences during the 2023 American Academy of Pediatrics National Conference & Exhibition.
Exome sequencing should be used for diagnosing cerebral palsy
October 13th 2023A systematic review and meta-analysis found that such sequencing indeed has an equivalent high genetic diagnostic yield in cerebral palsy, which supports including this neurodevelopmental disorder among those for which diagnostic exome sequencing should be used.
Is ADHD associated with shorter-than-expected height?
October 10th 2023To assess the role of familial factors, investigators analyzed data for a family-based group created from another Swedish national register that included 833,172 individuals without ADHD with different levels of relatedness to the individuals with ADHD and a group of matched controls.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.
